Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Privia Health Group, Inc. has received a consensus rating of "Moderate Buy" from 14 research firms, with 11 firms assigning a buy rating and one a strong buy rating.
• The average 12-month price target for the stock among analysts is $28.58, with recent target price adjustments ranging from $28.00 to $36.00.
• Despite reporting a revenue increase of 23.4% year-over-year, Privia Health missed earnings expectations, posting an EPS of $0.02 compared to the consensus estimate of $0.05.

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has earned an average rating of "Moderate Buy" from the fourteen analysts that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $28.5833.

A number of research analysts have recently issued reports on the stock. Stephens reaffirmed an "overweight" rating and issued a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, September 4th. JMP Securities lifted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "market outperform" rating in a research report on Friday, August 29th. Barclays lifted their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 27th. Citigroup reaffirmed an "outperform" rating on shares of Privia Health Group in a research report on Friday, August 29th. Finally, Piper Sandler cut their price target on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a research note on Monday, August 11th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. US Bancorp DE boosted its holdings in Privia Health Group by 2.4% during the first quarter. US Bancorp DE now owns 18,487 shares of the company's stock worth $415,000 after buying an additional 429 shares in the last quarter. Park Avenue Securities LLC boosted its holdings in Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock worth $342,000 after buying an additional 532 shares in the last quarter. Bank of Montreal Can boosted its holdings in Privia Health Group by 1.9% during the second quarter. Bank of Montreal Can now owns 28,694 shares of the company's stock worth $660,000 after buying an additional 543 shares in the last quarter. CWM LLC boosted its holdings in Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after buying an additional 604 shares in the last quarter. Finally, Financial Management Professionals Inc. boosted its holdings in Privia Health Group by 28.7% during the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock worth $76,000 after buying an additional 754 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA traded down $0.23 on Monday, reaching $22.37. The company's stock had a trading volume of 3,224,296 shares, compared to its average volume of 670,120. Privia Health Group has a 52-week low of $16.47 and a 52-week high of $26.09. The company has a market cap of $2.75 billion, a P/E ratio of 203.38, a PEG ratio of 3.28 and a beta of 0.82. The company has a 50-day simple moving average of $21.24 and a 200 day simple moving average of $22.45.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. During the same quarter in the previous year, the business earned $0.19 EPS. The company's quarterly revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. On average, equities research analysts forecast that Privia Health Group will post 0.14 EPS for the current fiscal year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.